2024 Digital Health Drug Development 
Lloyd Price
OCTOBER 14, 2024
Exec Summary: HLTH 2024 Las Vegas is expected to be a major event in the healthcare industry, focusing on innovation, collaboration, and the future of healthcare. Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. The impact of climate change on healthcare.
Digital Health Global
JANUARY 28, 2025
Growing industry confidence drives shift in digital strategy for clinical trial sponsors PALO ALTO, Calif.–(BUSINESS Recently, the company launched Medable AI and Medable Studio to automatically convert outcomes assessments into fully digital eCOAs in seconds now accessible on Google Cloud Marketplace. 5000 in 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
JANUARY 28, 2025
a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium links decentralized clinical trial (DCT) approaches to notably higher participation rates across multiple demographic groups. 5000 in 2024. PALO ALTO, Calif.–(BUSINESS
Digital Health Global
JANUARY 10, 2024
We are confident that the synergy between TNL’s unique Digital Cell Clones Lab platform and Debiopharm’s profound expertise in drug R&D will show the transformative potential of AI-enabled Digital Labs from disease-target discovery to the optimization of clinical trials.
Digital Health Global
JANUARY 29, 2025
a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium linking decentralized clinical trial (DCT) approaches to notably higher proportional representation among select demographic subgroups. 5000 in 2024. 5 at 9:55am.
Lloyd Price
SEPTEMBER 16, 2024
Exec Summary: The Morgan Stanley 22nd Annual Global Healthcare Conference was held in September 2024. Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are revolutionising the healthcare industry, from drug discovery to patient diagnosis and treatment. Key themes discussed during the conference included: 1.
Digital Health Global
JANUARY 25, 2024
Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. from January 23-25, 2024. Debiopharm is headquartered in Lausanne, Switzerland, and will be presenting at the 7th Annual DDR Inhibition Conference in Boston from January 29-30, 2024.
Expert insights. Personalized for you.
55 
Let's personalize your content